Efficacy of carrellizumab combined with hepatic arterial chemoembolization in the treatment of primary liver cancer and its effect on T lymphocyte subsets, tumor markers levels

doi:10.3969/j.issn.1672-3384.2024.01.012

ZUO Yi-fan, CHEN Xiao-liang, WU Su-fang, YAN Jiang-tao

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (1) : 56-60.

PDF(414 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (1) : 56-60. DOI: 10.3969/j.issn.1672-3384.2024.01.012

Original Article

Efficacy of carrellizumab combined with hepatic arterial chemoembolization in the treatment of primary liver cancer and its effect on T lymphocyte subsets, tumor markers levels

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(1): 56-60 https://doi.org/10.3969/j.issn.1672-3384.2024.01.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(414 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-07-27	2024-01-31
Issue Date
2024-01-31

Please choose a citation manager

Content to export